Cell And Gene Articles, App Notes, Case Studies, & White Papers

31. Enhancing Safety And Efficacy Of mRNA-Based Therapeutics 2/11/2025

    Discover how Codex® HiCap RNA Polymerase optimizes mRNA yield while reducing dsRNA byproducts for safer, more effective therapeutics.

32. Quantifying Lentiviral Physical Titer Using The QIAcuity dPCR System 7/14/2025

    Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.

33. Predicting Antibody-Dependent Cell-Mediated Cytotoxicity 10/11/2024

    We developed and validated a dual screening procedure (genotype and phenotype) for Lonza human peripheral blood mononuclear cells (PBMCs) to identify donors with high ADCC potential.

34. Optimize DNA Clearance In High-Salt, GMP-Grade Purification Processes 9/16/2025

    Efficient hcDNA removal is vital for therapeutic safety and compliance. Discover how salt-active enzymes support high-salt purification workflows to help manufacturers meet strict regulatory standards.

35. Enhancing Novel Developability Through Automated MS Analytics 1/29/2026

    Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.

36. 12.5x Titer Boost Accelerates CAR-T Program To IND Filing 3/4/2026

    Plasmid engineering and process development boosted viral titer 12.5×, eliminating manufacturing bottlenecks and enabling an on‑time regulatory submission for the cell therapy program.

37. Innovation In Filtration 3/18/2025

    Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.

38. Stability Of Supplemented PRIME-XV T Cell CDM At Room Temperature 10/17/2025

    Gain insight into how a supplemented medium stored at room temperature for up to 72 hours maintained T cell expansion performance, showing consistent viability and marker expression.

39. A Bright Future For Eye Care: The Advanced Therapy Revolution Is Here 4/10/2025

    Groundbreaking cell and gene therapies are revolutionizing eye care. Discover how advanced treatments target root causes, offering unprecedented hope for conditions previously deemed untreatable.

40. Improved Cell Viability For Multi-Day Cell-Based Assays 7/24/2025

    Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.